• Samsung Biologics, of Seoul, South Korea, and Roche AG, of Basel, Switzerland, said they entered a long-term strategic manufacturing agreement under which Samsung will manufacture Roche’s commercial biologic medicines at its two manufacturing facilities in Incheon, South Korea.